Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Porustobart |
| Trade Name | |
| Synonyms | HBM4003|HBM 4003|HBM-4003 |
| Drug Descriptions |
Porustobart (HBM4003) is an antibody against cytotoxic T lymphocyte-associated protein 4 (CTLA-4), which may stimulate anti-tumor immune response (PMID: 40378055). |
| DrugClasses | CTLA4 Antibody 34 |
| CAS Registry Number | 2649372-91-6 |
| NCIT ID | C173540 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Pembrolizumab + Porustobart | Pembrolizumab Porustobart | 0 | 1 |
| Porustobart | Porustobart | 0 | 0 |
| Porustobart + Toripalimab-tpzi | Porustobart Toripalimab-tpzi | 0 | 0 |